Current research has shown depressive symptoms are associated with sleep disturbances and misalignment of circadian rhythms. A chronobiological intervention combined with the usual antidepressant treatment may improve depressive symptoms along with sleep quality and circadian rhythms in patients with depression. This feasibility study was carried out with 38 participants: 21 outpatients suffering from non-seasonal major depressive disorder (MDD) and 17 healthy volunteers (general population). Patients were randomly assigned to two groups: 11 patients received a chronobiological intervention which consisted of regular specified daylight exposure for 14 days in conjunction with pharmacological treatment (LIGHT group), while 10 patients received only treatment-a-usual (TAU group). Depressive severity at inclusion was assessed with the Montgomery-Asberg Depression Scale and the International Neuropsychiatric Interview was used to exclude comorbid psychiatric disorders. The evolution of depressive symptoms was assessed using the Quick Inventory of Depressive Symptomatology-Self Report. Patients’ chronotype was evaluated with the Munich Chronotype Questionnaire and sleep with Pittsburgh Sleep Quality Index and a sleep agenda. In addition, circadian parameters (motor activity, skin temperature and light exposure) were assessed using the Kronowise® device and target sleep quality indices were calculated. Depressive patients undergoing psychopharmacological treatment, who received a specific instruction to increase their exposure to daylight improved their depressive symptoms, sleep quality, motor activity and peripheral temperature rhythms more than the TAU group.
扫码关注我们
求助内容:
应助结果提醒方式:
